Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +15%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (495)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04650204	Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy	terminated	Phase 4	4	Mayo ClinicOTHER	1	Jun 22, 2023	clinicaltrials
NCT01756729	Post-approval Study of NovoTTF-100A in Recurrent GBM Patients	terminated	Phase 4	13	NovoCure Ltd.INDUSTRY	1	Mar 2, 2016	clinicaltrials